A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This is a multicenter, open label, randomized, allopurinol-controlled, parallel-design study. Approximately 120 subjects will be randomly assigned in 1:1 ratio to receive febuxostat, or allopurinol for subjects with gout.
Epistemonikos ID: 5dc7f290a4acbb958ea33393e9e3d8229191613d
First added on: May 11, 2024